Additional RTKs, including the tumor metastasis-promoting Platelet-derived growth factor (PDGF), VEGFR, and VEGFR2 receptors, appear essential for tumor growth (García-Aranda and Redondo, 2019). The gene discussed is KDR; the disease is neoplasm.